Seeing Is Believing
TXG is currently covered by 11 analysts with an average price target of $40.61. This is a potential upside of $9.81 (31.85%) from yesterday's end of day stock price of $30.8.
10X Genomics's activity chart (see below) currently has 35 price targets and 56 ratings on display. The stock rating distribution of TXG is 71.43% BUY, 11.43% SELL and 17.14% HOLD.
Analysts average stock forecasts to be materialized ratio is 49.85% with an average time for these price targets to be met of 33.18 days.
Highest price target for TXG is $70, Lowest price target is $30, average price target is $40.61.
Most recent stock forecast was given by DANIEL ARIAS from STIFEL on 16-Feb-2024.
Currently out of the existing stock ratings of TXG, 25 are a BUY (71.43%), 4 are a SELL (11.43%), 6 are a HOLD (17.14%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
63
$26.5 (72.60%)
68
2 months 2 days ago
2/4 (50%)
$14.55 (30.03%)
42
Buy
55
$18.5 (50.68%)
47
2 months 24 days ago
1/4 (25%)
$12.6 (29.72%)
69
Buy
4 months 5 days ago
2/2 (100%)
$4.28 (7.68%)
10
Hold
54
$17.5 (47.95%)
35
4 months 6 days ago
3/3 (100%)
$5.36 (11.02%)
19
Hold
44
$7.5 (20.55%)
62
5 months 11 days ago
4/5 (80%)
$4.98 (12.76%)
21
What is TXG (10X Genomics) average time for price targets to be met?
Which analyst has the current highest performing score on TXG (10X Genomics) with a proven track record?
Which analyst has the most public recommendations on TXG (10X Genomics)?
Which analyst is the currently most bullish on TXG (10X Genomics)?
Which analyst is the currently most reserved on TXG (10X Genomics)?